Information

  • Dec 19, 2024

Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges

On Wednesday, the FDA approved Mesoblast Limited’s (NASDAQ:MESO) Ryoncil (remestemcel-L) as the first mesenchymal stromal cell (MSC) therapy in the U.S. Ryoncil is the only MSC therapy approved in the U.S. for any indication and the only therapy for steroid-refractory acute graft versus host disease (SR-aGvHD) in children 2 months and older, including adolescents. Ryoncil contains MSCs, a type of cell that can have various roles in the body and can differentiate into multiple other types of cell

  • Dec 19, 2024

Why Is Penny Stock Canoo Falling On Thursday?

Canoo Inc. (NASDAQ:GOEV) shares are trading lower in the premarket session on Thursday. The company is grappling with major financial challenges, leading to the furlough of 82 employees and the temporary shutdown of its factories in Oklahoma. The move comes as the electric vehicle manufacturer works to secure the necessary capital to continue its operations. Canoo is currently in advanced discussions with multiple capital sources but acknowledges the tough decision to furlough staff, particularl

  • Dec 19, 2024

Morning Bid: Markets fear Fed floor at 4%, dollar booms

Although the Federal Reserve's "hawkish cut" on Thursday had been broadly expected, markets now fear 4% policy rates will be the floor for the coming year at least - and no further easing until midyear or later. The picture painted by the Fed removes monetary easing as tailwind from the stock market for months and has seen the dollar rocket to its highest in more than two years - bowling over emerging, developed and crypto currencies alike. Lifting their median inflation forecast for next year by 0.3 percentage point to 2.5% but only nudging the GDP growth up a tenth to 2.1%, Fed policymakers also raised their policy rate forecasts for the next two years by half a point to 3.9% and 3.4% respectively.

  • Dec 19, 2024

Seeking Up to 15% Dividend Yield? Analysts Say These 2 Dividend Stocks Look Attractive

Stock investing ultimately revolves around generating returns. Achieving this goal requires building a strategically curated portfolio focused on value creation. While growth stocks often take center stage, incorporating high-yield dividend stocks can provide stability and bolster overall performance. Reliable dividends ensure a regular income stream, and high yields can beat the prevailing interest rates. While dividend stocks are usually considered a defensive stance, the best of these income-

  • Dec 19, 2024

Analysis-US stocks face headwind from rising yields after Fed signals fewer rate cuts

NEW YORK (Reuters) -The rally in U.S. stocks is encountering a fresh hurdle -- a potentially problematic rise in Treasury yields as the Federal Reserve signals fewer interest rate cuts for 2025. The central bank's rate outlook on Wednesday included only two cuts in the coming year, rather than the four previously penciled in, catching investors off guard, and sending stocks tumbling while driving up yields and the dollar. That overshadowed the Fed's widely expected decision to reduce its benchmark rate for a third straight meeting.

  • Dec 19, 2024

The Ultimate Guide to Investing in Bitcoin for Maximum Returns

Bitcoin (CRYPTO: BTC) continues to prove that it's one of the best financial assets to own. Any investor, whether the focus is on stocks or cryptocurrencies, certainly understands the concept of buying low and selling high. Bitcoin has had many declines of more than 50%.

Popular Post